Last edition
News about "Skyhawk Therapeutics"
Skyhawk Therapeutics has entered a strategic research collaboration worth over USD 2 billion with Merck KGaA, Darmstadt, Germany to develop novel RNA-targeting small molecules for neurological disorders.
Skyhawk Therapeutics | 19/08/2025 | By Mrinmoy Dey
Skyhawk Gets Australian Regulatory Approval to Extend SKY-0515 Treatment Duration
HREC also agreed to the inclusion of Volumetric MRI (vMRI) measurements as an early exploratory endpoint in the trial.
Skyhawk Therapeutics | 11/12/2024 | By Aishwarya | 284
Skyhawk Therapeutics Inaugurates its State-of-the-Art Labs in Switzerland
Skyhawk Therapeutics, Inc. has expanded its facilities with its new state-of-the-art labs in Superlab Suisse, in Basel Switzerland.
Skyhawk Therapeutics | 26/06/2024 | By Aishwarya | 617
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy